Home
>
National Drug Code (NDC)
>
Comtan
Comtan - 0078-0327-05 - (entacapone)
Drug Information of Comtan
| Product NDC: | 0078-0327 |
| Proprietary Name: | Comtan |
| Non Proprietary Name: | entacapone |
| Active Ingredient(s): | 200 mg/1 & nbsp; entacapone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Comtan
| Product NDC: | 0078-0327 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020796 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991019 |
Package Information of Comtan
| Package NDC: | 0078-0327-05 |
| Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0327-05) |
NDC Information of Comtan
| NDC Code | 0078-0327-05 |
| Proprietary Name | Comtan |
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0078-0327-05) |
| Product NDC | 0078-0327 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | entacapone |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19991019 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | ENTACAPONE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC] |
